Trials / Completed
CompletedNCT00981786
24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol
Quality of 24-hour Intraocular Pressure Control Obtained With the Brinzolamide/Timolol Fixed Combination Compared With the Brimonidine/Timolol Fixed Combination When Added to Travoprost Monotherapy in Subjects With Open-angle Glaucoma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 29 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The proposed crossover study will compare for the first time the quality of 24-hour intraocular pressure control with the combination of travoprost and brinzolamide/timolol compared with travoprost and brimonidine/timolol in glaucoma patients insufficiently controlled with travoprost. This comparison may determine the real efficacy of the two fixed combinations when added to the prostaglandin. The design of the proposed study should facilitate a better understanding of the role of these medications in glaucoma management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brimonidine/timolol fixed combination drops added to travoprost | twice daily administration |
| DRUG | Brinzolamide/timolol fixed combination drops added to travoprost | twice daily dosing |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-09-01
- Completion
- 2010-12-01
- First posted
- 2009-09-22
- Last updated
- 2020-12-17
Source: ClinicalTrials.gov record NCT00981786. Inclusion in this directory is not an endorsement.